Rifamycin S CAS 13553-79-2 Ubunyulu > 97.5% (HPLC) Factory

Inkcazelo emfutshane:

Igama leMichiza: Rifamycin S

Izithethantonye: 1,4-Dideoxy-1,4-Dihydro-1,4-Dioxorifamycin

CAS: 13553-79-2

Ubunyulu: >97.5% (HPLC)

Umgubo weCrystalline oMthubi okanye oOrenji

I-Agent ye-Antibiotic ekumgangatho ophezulu

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Rifamycin S (CAS: 13553-79-2) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Iipropati zeMichiza:

Igama leMchiza	Rifamycin S
Izithethantonye	1,4-Dideoxy-1,4-Dihydro-1,4-Dioxorifamycin;Rifaximin EP Ukungcola E
Inombolo yeCAS	13553-79-2
Inombolo yeCAT	RF-PI2058
Ubume beStokhwe	Kwi-Stock, Umthamo weMveliso 500MT/Unyaka
Ifomula yeemolekyuli	C37H45NO12
Ubunzima beMolekyuli	695.76
Uvakalelo	Ubushushu Bubuthathaka
Ukujikeleziswa okuthe ngqo [α]20/D	+451.0°~+500.0° (C=0.1 kwi-MeOH)
Indawo yokunyibilika	201℃
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo weCrystalline oMthubi okanye oOrenji
Ilahleko ekomisweni	≤3.00% (4h 100℃)
Intsalela kwi-Ignition	≤0.50%
Izinto ezinxulumeneyo
Rifamycin-O	≤0.50%
I-Rifamycin-B	≤0.50%
Incopho enye	≤1.00%
Ukungcola ngokupheleleyo	≤2.50%
Ubunyulu / Indlela yokuHlalutya	>97.5% (HPLC)
I-Infrared Spectrum	Iyahambelana neSakhiwo
Proton NMR Spectrum	Iyahambelana neSakhiwo
Umgangatho woVavanyo	Umgangatho woShishino
Beka ubomi kwishelufa	Iinyanga ezingama-24 ukusuka kumhla wokuveliswa ukuba zigcinwe ngokufanelekileyo
Ukusetyenziswa	UNdoqo oPhakathi weNdibaniselwano yaMayeza eRifamycin

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

FAQ:

Isicelo:

I-Rifamycin S (CAS: 13553-79-2) ngundoqo ophakathi kwi-synthesis yamayeza e-rifamycin.I-Rifamycin S sisithinteli-ntsholongwane se-semi-synthetic.I-Rifamycin S yiquinone kunye ne-antibiotiki agnet ngokuchasene neebhaktheriya ze-Gram-positive (kuquka i-MRSA).I-Rifamycin S luhlobo lwe-oxidized ye-reversible oxidation-reduction system ebandakanya ii-electron ezimbini.I-Rifamycin S ivelisa iintlobo ze-oksijini ezisebenzayo (ROS) kwaye inqanda i-microsomal lipid peroxidation.I-Rifamycin S ingasetyenziselwa isifo sephepha kunye neqhenqa.I-rifamycins liqela lamayeza okubulala iintsholongwane anxulumene nekhemikhali afunyanwa ngokubiliswa kwiinkcubeko zaseStreptomycesmediterranei.Bakudidi lwamayeza okubulala iintsholongwane abizwa ngokuba yi-theansamycins equlathe iringi ye-macrocyclic egqitywe kwiindawo ezimbini ezingadibaniyo zenucleus enuka kamnandi.I-rifamycins kunye noninzi lwe-semisynthetic derivatives yazo zicheba uluhlu olubanzi lomsebenzi wokulwa neentsholongwane.Zisebenza kakhulu ngokuchasene ne-Gram-positive bacteria kunye ne-M. tuberculosis.Nangona kunjalo, zikwasebenza ngokuchasene ne-Gram-negative bacteria kunye neentsholongwane ezininzi.I-Rifampin, i-asemisynthetic derivative ye-Rifamycin B, yakhutshwa njenge-agent ye-antitubercular e-United States ngo-1971. I-secondsemisynthetic derivative, i-rifabutin, yamkelwa ngo-1992 kunyango lwe-atypical mycobacterial infection.